Internal Medicine, Hematology & Oncology · Suffolk, VA
NPI
1174560015
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5838 Harbour View Blvd, Suite 105
Suffolk, VA, 23435
Phone (757) 484-0215
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.7M
209,845 services
Medicare patients, 2024
953
Average age 75
Drug cost, 2024
$5.9M
1,761 prescriptions
Company payments, 2025
$172
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Snehal A Damle was code J9271 (injection, pembrolizumab, 1 mg), 26,000 times for 22 patients. In total Snehal A Damle billed 209,845 services in 171 codes, and Medicare paid $3.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-08-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 26,000 | 22 | $44.77 | $1.2M |
| J1453 Injection, fosaprepitant, 1 mg | Office | 13,800 | 29 | $0.12 | $1,616 |
| J0185 Injection, aprepitant, 1 mg | Office | 9,880 | 18 | $1.35 | $13K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 9,460 | 19 | $2.32 | $22K |
| J9267 Injection, paclitaxel, 1 mg | Office | 7,422 | 12 | $0.08 | $590 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,487 | 72 | $0.09 | $220 |
| 85025 Blood Count | Office | 2,265 | 678 | $7.59 | $17K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,860 | 45 | $0.70 | $1,294 |
| 80053 Clinical Chemistry | Office | 1,706 | 659 | $10.33 | $18K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,230 | 32 | $0.25 | $305 |
| 36415 Venipuncture Blood Collection | Office | 1,135 | 472 | $8.62 | $9,784 |
| 96375 Injection Administration | Office | 988 | 96 | $11.58 | $11K |
| 82728 Clinical Chemistry | Office | 756 | 376 | $13.33 | $10K |
| 83550 Clinical Chemistry | Office | 750 | 375 | $8.55 | $6,412 |
| 83540 Clinical Chemistry | Office | 750 | 375 | $6.32 | $4,743 |
By year: 2022 $4.0M for 298,255 services; 2023 $3.6M for 216,290 services; 2024 $3.7M for 209,845 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,265 | 678 | $7.59 | $17K |
| 80053 Clinical Chemistry | 1,706 | 659 | $10.33 | $18K |
| 36415 Venipuncture Blood Collection | 1,135 | 472 | $8.62 | $9,784 |
| 82728 Clinical Chemistry | 756 | 376 | $13.33 | $10K |
| 83540 Clinical Chemistry | 750 | 375 | $6.32 | $4,743 |
| 83550 Clinical Chemistry | 750 | 375 | $8.55 | $6,412 |
| 82784 Immunoassay | 567 | 89 | $9.11 | $5,167 |
| 83520 Immunoassay | 334 | 78 | $16.93 | $5,653 |
| 82607 Clinical Chemistry | 310 | 228 | $14.74 | $4,568 |
| 82746 Clinical Chemistry | 287 | 211 | $14.36 | $4,122 |
Medicare prescription drug claims, 2024
In 2024, the drug Snehal A Damle prescribed most often to Medicare patients was Letrozole, with 185 prescriptions and refills. In total Snehal A Damle wrote 1,761 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 185 | 459 | 58 | $3,486 |
| Revlimid Lenalidomide | 153 | 153 | 18 | $2.0M |
| Eliquis Apixaban | 122 | 164 | 28 | $93K |
| Ondansetron Hcl Generic | 86 | 89 | 46 | $5,738 |
| Acyclovir Generic | 85 | 91 | 18 | $734 |
| Lenalidomide Generic | 64 | 64 | Under 11 | $799K |
| Dexamethasone Generic | 62 | 82 | 41 | $1,644 |
| Lansoprazole Generic | 58 | 76 | 15 | $908 |
| Exemestane Generic | 55 | 89 | 13 | $6,324 |
| Tamoxifen Citrate Generic | 52 | 125 | 21 | $1,792 |
| Gabapentin Generic | 40 | 44 | Under 11 | $306 |
| Olanzapine Generic | 40 | 48 | 26 | $381 |
| Brukinsa Zanubrutinib | 38 | 38 | Under 11 | $561K |
| Warfarin Sodium Generic | 34 | 76 | Under 11 | $190 |
| Ondansetron Odt Ondansetron | 32 | 32 | 14 | $804 |
Brand drugs: 515 claims; generic drugs: 1,246 claims; opioid claims: 86.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Snehal A Damle $172 ($172 in general payments such as food, travel and fees) from 2 companies. The largest payer was Array Biopharma Inc with $150.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.